A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medications

A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medications

Abstract In 2015, the World Health Organization (WHO) Expert Committee approved the addition of 16 cancer medicines to the WHO Model List of Essential Medicines (EML), bringing the total number of cancer medicines on the list to 46. This change represented the first major revision to the EML oncolog...

Full description

Bibliographic Details
Main Authors: Sangita M. Baxi, Reed Beall, Joshua Yang, Tim K. Mackey
Format: Article
Language:English
Published: BMC 2019-09-01
Series:Globalization and Health
Subjects:
Model list of essential medicines
EML
Pharmaceuticals
Access to medicines
Cancer
Patent status
Online Access:http://link.springer.com/article/10.1186/s12992-019-0497-3

Similar Items

Similar Items